Skip to main content
PMC home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;95(6):481–486. doi: 10.1111/j.1349-7006.2004.tb03236.x

Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats

Hiroyuki Kohno 1,✉, Rikako Suzuki 1,2, Yumiko Yasui 3, Masashi Hosokawa 3, Kazuo Miyashita 3, Takuji Tanaka 1
PMCID: PMC11158596  PMID: 15182427

Abstract

Pomegranate (Punica granatum L.) seed oil (PGO) contains more than 70% cis(c)9,frans(f)11,c13–18:3 as conjugated linolenic acids (CLN). Our previous short‐term experiment demonstrated that seed oil from bitter melon (Momordica charantia) (BMO), which is rich in c9,t11,t13‐CLN, inhibited the occurrence of colonic aberrant crypt foci (ACF) induced by azoxymethane (AOM). In this study, we investigated the effect of dietary PGO on the development of AOM‐induced colonic malignancies and compared it with that of conjugated linoleic acid (CLA). To induce colonic tumors, 6‐week old male F344 rats were given subcutaneous injections of AOM (20 mg/kg body weight) once a week for 2 weeks. One week before the AOM treatment they were started on diet containing 0.01%, 0.1%, or 1%±PGO or 1% CLA for 32 weeks. Upon termination of the bioassay (32 weeks) colon tumors were evaluated histopathologically. AOM exposure produced colonic adenocarcinoma with an incidence of 81% and multiplicity of 1.88±1.54 at week 32. Administration of PGO in the diet significantly inhibited the incidence (AOM+0.01% PGO, 44%, P<0.05; AOM+0.1% PGO, 38%, P<0.01; AOM+1% PGO, 56%) and the multiplicity (AOM+0.01% PGO, 0.56±0.73, P<0<01; AOM+0.1% PGO, 0.50±0.73, P<0.005; AOM+1% PGO, 0.88±0.96, P<0.05) of colonic adenocarcinomas, although a clear dose‐response relationship was not observed at these dose levels. CLA feeding also slightly, but not significantly, reduced the incidence and multiplicity of colonic adenocarcinomas. The inhibition of colonic tumors by PGO was associated with an increased content of CLA (c9,t11–18:2) in the lipid fraction of colonic mucosa and liver. Also, administration of PGO in the diet elevated expression of peroxisome proliferator activated receptor (PPAR) γ protein in the nontumor mucosa. These results suggest that PGO rich in c9,t11,c13‐CLN can suppress AOM‐induced colon carcinogenesis, and the inhibition is associated in part with the increased content of CLA in the colon and liver and/or increased expression of PPARγ protein in the colon mucosa.

References

  • 1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23–47. [DOI] [PubMed] [Google Scholar]
  • 2. Tanaka T. Effect of diet on human carcinogenesis. Crit Rev Oncol/Hematol 1997; 25: 73–95. [DOI] [PubMed] [Google Scholar]
  • 3. Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A. Environmental factors of cancer of colon and rectum. Cancer 1969; 23: 1210–20. [DOI] [PubMed] [Google Scholar]
  • 4. Reddy BS, Tanaka T, Simi B. Effect of different levels of dietary trans fat or corn oil on azoxymethane‐induced colon carcinogenesis in F344 rats. J Natl Cancer Inst 1985; 75: 791–8. [PubMed] [Google Scholar]
  • 5. Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 1999; 20: 2209–18. [DOI] [PubMed] [Google Scholar]
  • 6. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001; 61: 1927–33. [PubMed] [Google Scholar]
  • 7. Caygill CPJ, Charland SL, Lippin JA. Fat, fish oil, and cancer. Br J Cancer 1996; 74: 159–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Fernandez E, Chatenoud L, La Vecchia C, Negri E, Franceschi S. Fish consumption and cancer risk. Am. J Clin Nutr 1999; 70: 85–90. [DOI] [PubMed] [Google Scholar]
  • 9. Reddy BS, Burill C, Rigotty J. Effect of diets high in omega‐3 and omega‐6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991; 51: 487–91. [PubMed] [Google Scholar]
  • 10. Kohno H, Yamaguchi N, Ohdoi C, Nakajima S, Odashima S, Tanaka T. Modifying effect of tuna orbital oil rich in docosahexaenoic acid and vitamin D3 on azoxymethane‐induced colonic aberrant crypt foci in rats. Oncol Rep 2000; 7: 1069–74. [DOI] [PubMed] [Google Scholar]
  • 11. Bird RR Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55–71. [DOI] [PubMed] [Google Scholar]
  • 12. Parodi PW. Cows' milk fat components as potential anticarcinogenic agents. J Nutr 1997; 127: 1055–60. [DOI] [PubMed] [Google Scholar]
  • 13. Ip C, Chin SF, Scimeca IA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 1991; 51: 6118–24. [PubMed] [Google Scholar]
  • 14. Belury MA, Nickel KP, Bird CE, Wu Y. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer 1996; 26: 149–57. [DOI] [PubMed] [Google Scholar]
  • 15. Ha YL, Storkson I, Pariza MW. Inhibition of benzo(fl)pyrene‐induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acids. Cancer Res 1990; 50: 1097–101. [PubMed] [Google Scholar]
  • 16. Petrik MBH, McEntee MF, Iohnson BT, Obukowicz MG, Whelan I. Highly unsaturated (n‐3) fatty acids, but not α‐linolenic, conjugated linoleic or γ‐linolenic acids, reduce tumorigenesis in ApcMin/+ mice. J Nutr 2000; 130: 2434–43. [DOI] [PubMed] [Google Scholar]
  • 17. Liew C, Schut HAI, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acids against 2‐amino‐3‐methylimidazo[4,5‐f]quinoline‐in‐duced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 1995; 16: 3037–43. [DOI] [PubMed] [Google Scholar]
  • 18. Xu M, Dashwood RH. Chemoprevention studies of heterocyclic amine‐induced colon carcinogenesis. Cancer Lett 1999; 143: 179–83. [DOI] [PubMed] [Google Scholar]
  • 19. Cheng IL, Futakuchi M, Ogawa K, Iwata T, Kasai M, Tokudome S, Hirose M, Shirai T. Dose response study of conjugated fatty acid derived from safflower oil on mammary and colon carcinogenesis pretreated with 7,12‐dimethylbenz[a]anthracene (DMBA) and 1,2‐dimethylhydrazine (DMH) in female Sprague‐Dawley rats. Cancer Lett 2003; 196: 161–8. [DOI] [PubMed] [Google Scholar]
  • 20. Belury MA. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002; 132: 2995–8. [DOI] [PubMed] [Google Scholar]
  • 21. Smith CR. Occurrence of unusual fatty acids in plants. Prog Chem. Fats Other Lipids 1971; 11: 137–77. [Google Scholar]
  • 22. Badami RC, Patil KB. Structure and occurrence of unusual fatty acids in minor seed oils. Prog Lipid Res 1981; 19: 119–53. [DOI] [PubMed] [Google Scholar]
  • 23. Suzuki R, Noguchi R, Ota T, Abe M, Miyashita K, Kawada T. Cytotoxic effect conjugated trienoic fatty acids on mouse tumor and human monocytic leukemia cells. Lipids 2001; 36: 477–82. [DOI] [PubMed] [Google Scholar]
  • 24. Igarashi M, Miyazawa T. Newly recognized effect of conjugated trienoic fatty acids on cultured human tumor cells. Cancer Lett 2000; 148: 173–9. [DOI] [PubMed] [Google Scholar]
  • 25. Kohno H, Suzuki R, Noguchi R, Hosokawa M, Miyashita K, Tanaka T. Dietary conjugated linolenic acid inhibits azoxymethane‐induced colonic aberrant crypt foci in rats. Jpn J Cancer Res 2002; 93: 133–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Michalik L, Wahli W. Peroxisome proliferator‐activated receptors: three isotypes for a multitude of functions. Curr Opin Biotechnol 1999; 10: 564–70. [DOI] [PubMed] [Google Scholar]
  • 28. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem 2000; 43: 527–50. [DOI] [PubMed] [Google Scholar]
  • 29. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator‐activated receptors alpha and delta. Proc Natl Acad Sci USA 1997; 94: 4312–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator‐activated receptors α and γ. Proc Natl Acad Sci USA 1997; 94: 4318–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Houseknecht KL, Vanden Heuvel JP, Moya‐Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty falfa rat. Biochem Biophys Res Common 1998; 244: 678–82. [DOI] [PubMed] [Google Scholar]
  • 32. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C, Spiegelman BM. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 1998; 4: 1046–52. [DOI] [PubMed] [Google Scholar]
  • 33. Brockman JA, Gupta RA, Dubois RN. Activation of PPARγ leads to inhibition of anchorage‐independent growth of human colorectal cancer cells. Gastroenterology 1998; 115: 1049–55. [DOI] [PubMed] [Google Scholar]
  • 34. Kohno H, Yoshitani S, Takashima S, Okumura A, Hosokawa M, Yamaguchi N, Tanaka T. Troglitazone, a ligand for peroxisome proliferator‐activated receptor y, inhibits chemically‐induced aberrant crypt foci in rats. Jpn J Cancer Res 2001; 92: 396–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Tanaka T, Kohno H, Yoshitani S, Takashima S, Okumura A, Murakami A, Hosokawa M. Ligands for peroxisome proliferator‐activated receptors α and y inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001; 61: 2424–8. [PubMed] [Google Scholar]
  • 36. Vanden Heuvel JP. Peroxisome proliferator‐activated receptors: a critical link among fatty acids, gene expression and carcinogenesis. J Nutr 1999; 129: 575S–80S. [DOI] [PubMed] [Google Scholar]
  • 37. American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 1977; 107: 1340–8. [DOI] [PubMed] [Google Scholar]
  • 38. Takagi T, Itabashi Y. Occurrence of mixtures of geometrical isomers of conjugated octadecatrienoic acid in some seed oils: analysis by open‐tubular gas liquid chromatography and high performance liquid chromatography. Lipids 1981; 16: 546–51. [Google Scholar]
  • 39. Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 1974; 30: 505–13. [PubMed] [Google Scholar]
  • 40. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497–509. [PubMed] [Google Scholar]
  • 41. Kramer JKG, Sehat N, Fritsche J, Mossoba MM, Eulitz K, Yurawecz MP, Ku Y. Separation of conjugated fatty acid isomers. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ, Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJS, editors. Advances in conjugated linoleic acid research. Champaign , IL : AOCS Press; 1999. p. 64–82. [Google Scholar]
  • 42. Sehat N, Kramer JKG, Mossoba MM, Yurawecz MP, Roach JAG, Eulitz K, Morehouse KM, Ku Y. Identification of conjugated linoleic acid isomers in cheese by gas chromatography, silver ion high performance liquid chromatography and mass spectral reconstructed ion profiles. Comparison of chromatographic elution sequences. Lipids 1998; 33: 963–71. [DOI] [PubMed] [Google Scholar]
  • 43. Josyula S, Schut HAJ. Effects of dietary conjugated linoleic acid on DNA adduct formation of PhIP and IQ after bolus administration to female F344 rats. Nutr Cancer 1998; 32: 139–45. [DOI] [PubMed] [Google Scholar]
  • 44. Jones PA, Lea LJ, Pendlington RU. Investigation of the potential of conjugated linoleic acid (Cla) to cause peroxisome proliferation in rats. Food Chem. Toxicol 1999; 37: 1119–25. [DOI] [PubMed] [Google Scholar]
  • 45. Panigrahy D, Shen LQ, Kieran MW, Kaipainen A. Therapeutic potential of thiazolidinediones as anticancer agents. Expert Opin Invest Drugs 2003; 12: 1925–37. [DOI] [PubMed] [Google Scholar]
  • 46. Subbaramaiah K, Lin DT, Hart JC, Dannenberg AJ. Peroxisome proliferator‐activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase‐2. Evidence for involvement of activator protein‐1 and CREB‐binding protein/p300. J Biol Chem. 2001; 276: 12440–8. [DOI] [PubMed] [Google Scholar]
  • 47. Suh N, Wang Y, Williams CR, Risingsong R, Gilmer T, Willson TM, Sporn MB. A new ligand for the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), GW7845, inhibits rat mammary carcinogenesis. Cancer Res 1999; 59: 5671–3. [PubMed] [Google Scholar]
  • 48. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H. Peroxisome proliferator‐activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 2003; 124: 361–7. [DOI] [PubMed] [Google Scholar]
  • 49. Moya‐Camarena SY, Vanden Heuvel JP, Belury MA. Conjugated linoleic acid activates peroxisome proliferator‐activated receptor α and β subtypes but does not induce hepatic peroxisome proliferation in Sprague‐Dsawley rats. Biochim. Biophys Acta 1999; 1436: 331–42. [DOI] [PubMed] [Google Scholar]
  • 50. McCarty MF. Activation of PPARγ may mediate a portion of the anticancer activity of conjugated linoleic acid. Med Hypotheses 2000; 55: 187–8. [DOI] [PubMed] [Google Scholar]
  • 51. Noguchi R, Yasui Y, Suzuki R, Hosokawa M, Fukunaga K, Miyashita K. Dietary effects of bitter gourd oil on blood and liver lipids of rats. Arch Biochem. Biophys 2001; 396: 207–12. [DOI] [PubMed] [Google Scholar]
  • 52. Lee JS, Takai J, Takahasi K, Endo Y, Fujimoto K, Koike S, Matsumoto W. Effect of dietary tung oil on the growth and lipid metabolism of laying hens. J Nutr Sci Vitaminol 2002; 48: 142–8. [DOI] [PubMed] [Google Scholar]
  • 53. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 1994; 54: 1212–5. [PubMed] [Google Scholar]
  • 54. Ip C, Scimeca JA. Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesis. Nutr Cancer 1997; 27: 131–5. [DOI] [PubMed] [Google Scholar]
  • 55. Brown JM, Boysen MS, Jensen SS, Morrison RF, Storkson J, Lea‐Currie R, Pariza M, Mandrup S, Mclntosh MK. Isomer‐specific regulation of metabolism and PPARγ signaling by CLA in human preadipocytes. J Lipid Res 2003; 44: 1287–300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Dhar P, Ghosh S, Bhattacharyya DK. Dietary effects of conjugated octadecatrienoic fatty acid (9cis, 11trans, I3trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats. Lipids 1999; 34: 109–14. [DOI] [PubMed] [Google Scholar]
  • 57. Cosgrove JP, Church DF, Pryor WA. The kinetics of the autoxidation of polyunsaturated fatty acids. Lipids 1987; 22: 299–304. [DOI] [PubMed] [Google Scholar]
  • 58. Ha YL, Grimm NK, Pariza MW. Anticarcinogens from fried ground beef: heat‐altered derivatives of linoleic acid. Carcinogenesis 1987; 8: 1881–7. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES